Technology Features & Specifications
Typical diagnostic methods such as CT and MRI are invasive in nature and require tissue samples for analysis, affecting the normal functions of organs and causing different side effects. On the contrary, prostate cancer screening is an attempt to detect unsuspected cancers in their very early stage by a simple mean. It may be used to gear up for more specific follow-up diagnostic tests, and, if required, cancer treatments. We developed a cheap and accurate screening test that can minimize the large medical cost brought by those expensive and tedious diagnostic tests for confirmation, which, regrettably, usually come up with a negative result. Our technology features high sensitivity and accuracy, fast detection, noninvasive, simple to use and cost effective.
From our results, urinary spermine had demonstrated an exceptionally good diagnostic performance to distinguish the prostate cancer patients from non-cancerous cases, with results in accordance with the clinical standard of transrectal ultrasound prostatic biopsy results. Our technology can be described as the next-generation medical imaging reagents for prostate cancer detection that can even be used at home.
It serves as a complimentary test to serum prostate specific antigen (PSA) test